The Strategist is designed to surface useful, expert recommendations for things to buy across the vast e-commerce landscape.

The recall affects acne creams from well-known retailers such as Walgreens, La Roche-Posay, and Proactiv. The U.S. Food and Drug Administration (FDA) issued a recall notice on March 11th ...

Some popular skin care products, acne treatments, are being voluntarily recalled because they may contain elevated levels of a chemical that causes cancer, according to a notice posted this week ...

Meghan Markle and Kyle Richards both plugged La Roche-Posay’s Toleriane Hydrating Gentle Cleanser this month — and while the ...

Several acne products containing benzoyl peroxide have been recalled due to possible benzene contamination, the Food and Drug Administration (FDA) said this week.

The agency announced that after concerns were raised about levels of benzene in products containing benzoyl peroxide, they tested 95 acne products with the ingredient. While most had “undetectable or ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

La Roche-Posay Effaclar Duo Dual Action Acne Treatment and Proactiv Skin Smoothing Exfoliator are among the acne medications included in the voluntary recall for potential cancer-causing chemicals ...

Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...

Two months after U.S. President Donald Trump issued an executive order proclaiming diversity, equity and inclusion (DEI) programs “illegal and immoral,” Roche has scrapped its high-profile ...

La Roche-Posay has announced Tyler “Ninja” Blevins, pro gamer, streamer, and entertainer, as its new partner in the cause for the Save your Skin brand platform, dedicated to skin cancer prevention and ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies ...